Myeloma Paper of the Day, July 20th, suggested by Robert Orlowski
Robert Orlowski shared on X:
“Myeloma Paper of the Day: Small study on BCMA CAR T-treated patients finds correlation between outcomes & abundance & targeted cytotoxic activity of CD8+ effector CAR-T cells on day 28 after CAR-T cell infusion.”
Source: Robert Orlowski/X
Authors: Yazi Yang, Sen Qin, Mengyu Yang, Ting Wang, Ru Feng, Chunli Zhang, Enrun Zheng, Qinghua Li, Pengyu Xiang, Shangyong Ning, Xiaodong Xu, Xin Zuo, Shuai Zhang, Xiaoya Yun, Xuehong Zhou, Yue Wang, Lin He, Yongfeng Shang, Luyang Sun, and Hui Liu.
Other posts featuring Robert Orlowski on OncoDaily.
Robert Orlowski holds multiple positions at The University of Texas MD Anderson Cancer Center, including Chairman, Ad Interim Director of Myeloma, and Professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine.
Additionally, he chairs the SWOG Barlogie/Salmon Myeloma Committee, which is part of the National Clinical Trials Network, dedicated to advancing new therapies and understanding the biology of myeloma.
